Elan trials favourable

Elan, the Dublin-based but US quoted drugs company has announced "promising" results from a Multiple Sclerosis drugs trail

Elan, the Dublin-based but US quoted drugs company has announced "promising" results from a Multiple Sclerosis drugs trail. Elan said on Saturday that that the results of clinical trails of Antegren were promising and "suggest that the agent mechanism of action has potential as a new approach to treating MS".

  • —

    From maternity leave to remote working: Submit your work-related questions here

  • Listen to Inside Business podcast for a look at business and economics from an Irish perspective

  • Sign up to the Business Today newsletter for the latest new and commentary in your inbox